Abstract 2740: Influence of the American Heart Association’s Get with the Guidelines Heart Failure (GWTG-HF) Program on Emerging Performance Measures for Patients Hospitalized with Heart Failure
Background: Get With The Guidelines-Heart Failure (GWTG-HF) is a national initiative of the AHA to improve guidelines adherence in patients hospitalized with HF. While GWTG-HF has been associated with improvements in established HF performance measures (PM), the influence on newer therapies and emerging HF PM has not been studied.
Methods: GWTG-HF employs a collaborative model of care and a web-based patient management tool (Outcome Inc) for data collection, decision support, on-demand reporting, and patient education. Baseline data on emerging and established PM were collected for 30 consecutive patients per hospital and are then reported quarterly. Emerging PM include anticoagulation with AFib, aldosterone antagonists, hydralazine/nitrates in Black patients, evidence based beta blocker use, and ICD in LVEF ≤30. All measures are reported as % eligible patients receiving the evidence-based intervention.
Results: Data from 97 hospitals and 18,516 HF patients were collected from 1/05–3/06. Mean age was 72.9 ± 14.2 years old, 50.0% female, 16.3% Black, 47.2% ischemic etiology, and mean LVEF 38.7 ± 17.1 (50% with LVSD). Significant improvements were observed over 4 quarters following baseline in 2 of 5 emerging PM compared to 4 of 5 established PM.
Conclusions: Conformity with emerging performance measures was substantially below that for established performance measures and there was less improvement in these measures over time in GWTG-HF. Further improvements in the effectiveness of HF care delivery will require greater focus on newer guideline recommended therapies.